Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3159-07-7

Post Buying Request

3159-07-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3159-07-7 Usage

Chemical Properties

Off-White Powder

Uses

Dibenzo[b,f][1,4]thiazepine-11-[10H]one (Quetiapine EP Impurity G; Quetiapine Impurity G; Quetiapine USP-G) is an intermediate in the synthesis of quetiapine (Q510000).

Check Digit Verification of cas no

The CAS Registry Mumber 3159-07-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,1,5 and 9 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3159-07:
(6*3)+(5*1)+(4*5)+(3*9)+(2*0)+(1*7)=77
77 % 10 = 7
So 3159-07-7 is a valid CAS Registry Number.
InChI:InChI=1/C13H9NOS/c15-13-9-5-1-3-7-11(9)16-12-8-4-2-6-10(12)14-13/h1-8H,(H,14,15)

3159-07-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • USP

  • (1592781)  Quetiapine Related Compound G  United States Pharmacopeia (USP) Reference Standard

  • 3159-07-7

  • 1592781-15MG

  • 14,500.98CNY

  • Detail

3159-07-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name 10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine

1.2 Other means of identification

Product number -
Other names 10,11-Dihydro-11-oxo dibenzo-1,4-thiazepine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3159-07-7 SDS

3159-07-7Synthetic route

2-phenylthiophenyl isocyanate
13739-55-4

2-phenylthiophenyl isocyanate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
aluminum (III) chloride In 1,2-dichloro-benzene at 100 - 150℃; for 4h;100%
phenyl [2-(phenylsulphanyl)phenyl]carbamate
111974-73-3

phenyl [2-(phenylsulphanyl)phenyl]carbamate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With methanesulfonic acid; phosphorus pentoxide at 80 - 110℃; for 2.5h;96%
With polyphosphoric acid Heating;94%
With PPA In water87%
2-((2-aminophenyl)thio)benzoic acid
54920-98-8

2-((2-aminophenyl)thio)benzoic acid

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With PPA at 140℃; for 2h;95%
toluene-4-sulfonic acid In ethyl acetate; xylene at 125℃; for 10h;86%
With phosphorus pentoxide; xylene
bis(trichloromethyl) carbonate
32315-10-9

bis(trichloromethyl) carbonate

2-aminodiphenyl sulfide hydrochloride
6764-13-2

2-aminodiphenyl sulfide hydrochloride

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Stage #1: bis(trichloromethyl) carbonate; 2-aminodiphenyl sulfide hydrochloride In chloroform for 10h; Reflux; Large scale;
Stage #2: With toluene-4-sulfonic acid In chloroform at 120℃; for 3h; Large scale;
93.7%
methyl 2-(2-nitrophenylthio)[14C]benzoate
4892-03-9

methyl 2-(2-nitrophenylthio)[14C]benzoate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With acetic acid; zinc Reagent/catalyst; Reflux;93.4%
Stage #1: methyl 2-(2-nitrophenylthio)[14C]benzoate With tin(II) chloride dihdyrate In ethanol
Stage #2: With trimethylaluminum In dichloromethane at 45 - 100℃;
40%
Multi-step reaction with 2 steps
1: ethyl acetate; Raney nickel / Hydrogenation
2: 220 °C
View Scheme
Multi-step reaction with 2 steps
1: Raney nickel; ethanol / Hydrogenation
2: 220 °C
View Scheme
Multi-step reaction with 2 steps
1.1: iron(III) chloride; pyrographite / 0.5 h / 65 °C
1.2: 12 h / 65 °C
2.1: sodium methylate / toluene / 24 h / 110 °C
View Scheme
benzyl 2-(2-nitrophenylthio)benzoate

benzyl 2-(2-nitrophenylthio)benzoate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With palladium 10% on activated carbon; hydrogen In methanol at 20℃; under 1500.15 Torr; Reagent/catalyst;85.4%
9H-thioxanthen-9-one oxime
20169-45-3

9H-thioxanthen-9-one oxime

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With toluene-4-sulfonic acid In toluene Reagent/catalyst; Solvent; Reflux;81.5%
With phosphorus pentachloride In diethyl ether Ambient temperature;
2-(2-nitrophenylthio)benzoic acid methyl ester
100866-62-4

2-(2-nitrophenylthio)benzoic acid methyl ester

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With sodium methylate In toluene at 110℃; for 24h; Temperature; Reagent/catalyst;80.1%
With acetic acid at 135℃;72%
at 220℃;
2-(2-aminophenylthio)benzoic acid ethyl ester

2-(2-aminophenylthio)benzoic acid ethyl ester

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With sodium methylate In toluene at 110℃; for 24h;79.6%
carbon monoxide
201230-82-2

carbon monoxide

(2-aminophenyl)-2’-bromophenyl sulfide
63107-77-7

(2-aminophenyl)-2’-bromophenyl sulfide

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With dmap; bis(dibenzylideneacetone)-palladium(0); catacxium A In toluene at 100℃; for 18h; Sealed tube;76%
2-iodophenylamine
615-43-0

2-iodophenylamine

Methyl thiosalicylate
4892-02-8

Methyl thiosalicylate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With rongalite; sodium hydroxide In dimethyl sulfoxide at 90℃; for 48h; Inert atmosphere; Schlenk technique; Sealed tube;70%
2-phenylsulfanyl-aniline
1134-94-7

2-phenylsulfanyl-aniline

phenyl chloroformate
1885-14-9

phenyl chloroformate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With sodium carbonate In toluene62%
o-iodo-methyl-benzoic acid
610-97-9

o-iodo-methyl-benzoic acid

2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With copper(II) ferrite; potassium tert-butylate In N,N-dimethyl-formamide for 24h; Reflux; Inert atmosphere;60%
2-(2-trifluoroacetylaminophenylthio)benzoic acid
155882-74-9

2-(2-trifluoroacetylaminophenylthio)benzoic acid

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With trifluoroacetic anhydride In N,N-dimethyl-formamide 1.) reflux, 1 h, 2.) RT, overnight;55%
2‑(2‑nitrophenylsulfanyl)benzoic acid
19806-43-0

2‑(2‑nitrophenylsulfanyl)benzoic acid

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With tributylphosphine at 140℃; for 48h; Schlenk technique; regioselective reaction;51%
Multi-step reaction with 2 steps
1: ethyl acetate
2: triethylamine; benzotriazol-1-ol / dichloromethane
View Scheme
Multi-step reaction with 2 steps
1: hydrogen; palladium on activated charcoal / ethyl acetate / 20 °C
2: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; benzotriazol-1-ol; triethylamine / dichloromethane / 12 h / 20 °C
View Scheme
2-phenyl-1,2-benzisothiazolin-3-one
2527-03-9

2-phenyl-1,2-benzisothiazolin-3-one

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
In tert-butyl alcohol for 2h; Irradiation;31%
In tert-butyl alcohol for 1.5h; Irradiation;31%
2-chloro-3-aminopyridine
6298-19-7

2-chloro-3-aminopyridine

Thiosalicylic acid
147-93-3

Thiosalicylic acid

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
In 1,2-dichloro-benzene for 0.8h; Reflux;26%
2-phenyl-1,2-benzisothiazolin-3-one
2527-03-9

2-phenyl-1,2-benzisothiazolin-3-one

A

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

B

2-phenyl-1,2-benzisothiazol-3(2H)-one 1-oxide

2-phenyl-1,2-benzisothiazol-3(2H)-one 1-oxide

Conditions
ConditionsYield
With oxygen In benzene for 2h; Product distribution; Irradiation; other solvents; without oxygen.;A 15%
B 8%
With N-chloro-succinimide; potassium hydrogencarbonate 1) CH2Cl2, 0 deg C, 20 min; 2) water, 1 h.; Yield given. Multistep reaction;
carbon dioxide
124-38-9

carbon dioxide

2-phenylsulfanyl-aniline
1134-94-7

2-phenylsulfanyl-aniline

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With n-butyllithium 1) ether, room temperature, 30 h, 2) ether; Yield given. Multistep reaction;
2-(2-aminophenylthio)benzoic acid hydrochloride

2-(2-aminophenylthio)benzoic acid hydrochloride

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dioxane / 18 h / Ambient temperature
2: 55 percent / trifluoroacetic anhydride / dimethylformamide / 1.) reflux, 1 h, 2.) RT, overnight
View Scheme
2,2'-dithiodibenzoic acid dichloride
19602-82-5

2,2'-dithiodibenzoic acid dichloride

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2) bromine; 3) basic alumina
2: 31 percent / 2-methyl-propan-2-ol / 2 h / Irradiation
View Scheme
aniline
62-53-3

aniline

ethane-α.β-bis-sulfonic acid chloride

ethane-α.β-bis-sulfonic acid chloride

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 2) bromine; 3) basic alumina
2: 31 percent / 2-methyl-propan-2-ol / 2 h / Irradiation
View Scheme
2-Chloronitrobenzene
88-73-3

2-Chloronitrobenzene

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: ethyl acetate; Raney nickel / Hydrogenation
3: 220 °C
View Scheme
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: Raney nickel; ethanol / Hydrogenation
3: 220 °C
View Scheme
Multi-step reaction with 4 steps
1: sodium hydroxide / dimethyl sulfoxide / 80 °C
2: hydrogen / methanol / 4137.29 Torr
3: sodium carbonate / tetrahydrofuran; water
4: PPA / 100 °C
View Scheme
Methyl thiosalicylate
4892-02-8

Methyl thiosalicylate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: ethyl acetate; Raney nickel / Hydrogenation
3: 220 °C
View Scheme
Multi-step reaction with 3 steps
1: methanol. sodium methylate
2: Raney nickel; ethanol / Hydrogenation
3: 220 °C
View Scheme
thioxanthene-9-thione
3591-73-9

thioxanthene-9-thione

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: hydroxylamine
2: PCl5 / diethyl ether / Ambient temperature
View Scheme
2-Iodobenzoic acid
88-67-5

2-Iodobenzoic acid

2-amino-benzenethiol
137-07-5

2-amino-benzenethiol

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With potassium hydroxide; copper In water
sulfuric acid
7664-93-9

sulfuric acid

2-(2-aminophenylthio)-benzonitrile
140425-65-6

2-(2-aminophenylthio)-benzonitrile

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
With acetic acid In 5,5-dimethyl-1,3-cyclohexadiene; water
With acetic acid In 5,5-dimethyl-1,3-cyclohexadiene; water
2-nitrophenyl phenyl sulfide
4171-83-9

2-nitrophenyl phenyl sulfide

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: hydrogen / methanol / 4137.29 Torr
2: sodium carbonate
3: polyphosphoric acid / Heating
View Scheme
Multi-step reaction with 3 steps
1: hydrogen / methanol / 4137.29 Torr
2: sodium carbonate / tetrahydrofuran; water
3: PPA / 100 °C
View Scheme
Multi-step reaction with 2 steps
1.1: iron / ethanol / 1.5 h / Reflux; Large scale
1.2: 15 °C / pH 1 / Large scale
2.1: chloroform / 10 h / Reflux; Large scale
2.2: Polyphosphoric acid / 3 h / 120 °C / Large scale
View Scheme
Multi-step reaction with 3 steps
1: iron; ammonium chloride / water
2: sodium carbonate / toluene
3: polyphosphoric acid / 8 h / 100 - 105 °C
View Scheme
2-phenylsulfanyl-aniline
1134-94-7

2-phenylsulfanyl-aniline

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium carbonate
2: polyphosphoric acid / Heating
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate / tetrahydrofuran; water
2: PPA / 100 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate
2: polyphosphoric acid / 80 - 90 °C
View Scheme
Multi-step reaction with 2 steps
1: sodium carbonate / toluene
2: polyphosphoric acid / 8 h / 100 - 105 °C
View Scheme
Multi-step reaction with 2 steps
1.1: toluene / 0.08 h / 4 °C
1.2: 1.5 h / 4 °C
2.1: methanesulfonic acid; phosphorus pentoxide / 2.5 h / 80 - 110 °C
View Scheme
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

11-chloro-dibenzo[b,f][1,4]thiazepine
13745-86-3

11-chloro-dibenzo[b,f][1,4]thiazepine

Conditions
ConditionsYield
With trichlorophosphate In toluene at 100℃; for 12h; Inert atmosphere;99%
With N,N-dimethyl-aniline; trichlorophosphate at 106℃; for 6h; Heating / reflux;97%
With N,N-dimethyl-aniline; trichlorophosphate at 106℃; for 6h; Heating / reflux;97%
piperazine
110-85-0

piperazine

titanium(IV) isopropylate
546-68-9

titanium(IV) isopropylate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

A

11-(1-piperazinyl)dibenzo[b,f][1,4]thiazepine
5747-48-8

11-(1-piperazinyl)dibenzo[b,f][1,4]thiazepine

B

isopropyl alcohol
67-63-0

isopropyl alcohol

Conditions
ConditionsYield
at 170℃; for 5h; Heating / reflux;A 99%
B n/a
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

C13H10N2S*ClH
1176987-11-3

C13H10N2S*ClH

Conditions
ConditionsYield
With N,N-dimethyl-aniline; trichlorophosphate at 106℃; for 6h; Heating / reflux;97%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-[2-(1-piperazinyl)ethoxy]ethanol dihydrochloride monohydrate

2-[2-(1-piperazinyl)ethoxy]ethanol dihydrochloride monohydrate

(2E)-but-2-enedioic acid
110-17-8

(2E)-but-2-enedioic acid

11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine hemifumarate salt

11-[4-[2-(2-hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine hemifumarate salt

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With N,N-dimethyl-aniline; trichlorophosphate In chlorobenzene at 15 - 100℃; for 3h;
Stage #2: 2-[2-(1-piperazinyl)ethoxy]ethanol dihydrochloride monohydrate With sodium carbonate In dimethyl sulfoxide; chlorobenzene at 85 - 90℃; for 6 - 8h;
Stage #3: (2E)-but-2-enedioic acid In ethyl acetate at 0 - 62℃; for 2.5h; Product distribution / selectivity;
93%
1-(2-hydroxyethyl)piperazine
103-76-4

1-(2-hydroxyethyl)piperazine

titanium(IV) isopropylate
546-68-9

titanium(IV) isopropylate

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

A

O-Dealkyl Quetiapine
329216-67-3

O-Dealkyl Quetiapine

B

isopropyl alcohol
67-63-0

isopropyl alcohol

Conditions
ConditionsYield
at 170℃; for 5.5h; Heating / reflux;A 91%
B n/a
piperazine
110-85-0

piperazine

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

11-piperazin-1-yldibenzo[b,f][1,4]thiazepine hydrochloride
753475-15-9

11-piperazin-1-yldibenzo[b,f][1,4]thiazepine hydrochloride

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With trichlorophosphate In toluene at 10℃; for 4h; Heating / reflux;
Stage #2: With potassium carbonate In water; toluene at 15℃;
Stage #3: piperazine With hydrogenchloride more than 3 stages;
90%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

10,11-Dihydrodibenz[b,f][1,4]thiazepine
494-20-2

10,11-Dihydrodibenz[b,f][1,4]thiazepine

Conditions
ConditionsYield
With tris(2,4-pentanedionato)ruthenium(III); ytterbium(III) trifluoromethanesulfonate nonohydrate; hydrogen; [2-((diphenylphospino)methyl)-2-methyl-1,3-propanediyl]bis[diphenylphosphine] In tetrahydrofuran at 150℃; under 3750.38 Torr; for 15h; Autoclave;87%
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With hydrazine hydrate In ethylene glycol at 80℃; for 2h;
Stage #2: With potassium hydroxide In water for 2h; Reflux;
74%
With lithium aluminium tetrahydride
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

N-(p-tolyl)-2-chloroacetamide
16634-82-5

N-(p-tolyl)-2-chloroacetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-methylphenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-methylphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: N-(p-tolyl)-2-chloroacetamide In N,N-dimethyl-formamide at -5 - 30℃;
83%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

chloro-acetic acid-(2,6-dichloro-4-nitro-anilide)
138681-35-3

chloro-acetic acid-(2,6-dichloro-4-nitro-anilide)

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(2,6-dichloro-4-nitrophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(2,6-dichloro-4-nitrophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: chloro-acetic acid-(2,6-dichloro-4-nitro-anilide) In N,N-dimethyl-formamide at -5 - 30℃;
82%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-chloro-N-(3-chlorophenyl)acetamide
2564-05-8

2-chloro-N-(3-chlorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(3-chlorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(3-chlorophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(3-chlorophenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
82%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

bromoacetic acid methyl ester
96-32-2

bromoacetic acid methyl ester

(11-oxo-11H-dibenzo[b,f][1,4]thiazepin-10-yl)acetic acid methyl ester
1073181-74-4

(11-oxo-11H-dibenzo[b,f][1,4]thiazepin-10-yl)acetic acid methyl ester

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide; mineral oil at 60℃; for 0.166667h; Inert atmosphere;
Stage #2: bromoacetic acid methyl ester In N,N-dimethyl-formamide; mineral oil at 80℃; for 5h; Inert atmosphere;
79%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-chloro-N-(4-fluorophenyl)acetamide
351-04-2

2-chloro-N-(4-fluorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-fluorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-fluorophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(4-fluorophenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
78%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-chloro-N-(2,3-dichiorophenyl) acetamide
33560-47-3

2-chloro-N-(2,3-dichiorophenyl) acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(2,3-dichiorophenyl) acetamide In N,N-dimethyl-formamide at -5 - 30℃;
78%
2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-methoxyphenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-methoxyphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: N-(4-methoxyphenyl)-2-chloroacetamide In N,N-dimethyl-formamide at -5 - 30℃;
78%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-chloro-N-(4-chlorophenyl)acetamide
3289-75-6

2-chloro-N-(4-chlorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-chlorophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-chlorophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(4-chlorophenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
76%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

4-(2-chloroacetamido)acetophenone
38283-38-4

4-(2-chloroacetamido)acetophenone

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-acetylphenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-acetylphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 4-(2-chloroacetamido)acetophenone In N,N-dimethyl-formamide at -5 - 30℃;
76%
titanium(IV) isopropylate
546-68-9

titanium(IV) isopropylate

1-[2-(2-hydroxyethoxy)ethyl]piperazine
13349-82-1

1-[2-(2-hydroxyethoxy)ethyl]piperazine

dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

A

isopropyl alcohol
67-63-0

isopropyl alcohol

B

quetiapine fumarate
111974-72-2

quetiapine fumarate

Conditions
ConditionsYield
With pentan-1-ol at 160℃; for 32h; Product distribution / selectivity; Heating / reflux;A n/a
B 75%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-chloro-N-(3-methylphenyl)acetamide
32428-61-8

2-chloro-N-(3-methylphenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(3-methylphenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(3-methylphenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(3-methylphenyl)acetamide In N,N-dimethyl-formamide at -5 - 30℃;
74%
dibenzo[b,f][1,4]thiazepin-11-one
3159-07-7

dibenzo[b,f][1,4]thiazepin-11-one

2-chloro-N-(4-nitro-phenyl)-acetamide
17329-87-2

2-chloro-N-(4-nitro-phenyl)-acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-nitrophenyl)acetamide

2-(11-oxodibenzo[b,f][1,4]thiazepin-10(11H)-yl)-N-(4-nitrophenyl)acetamide

Conditions
ConditionsYield
Stage #1: dibenzo[b,f][1,4]thiazepin-11-one With sodium hydride In N,N-dimethyl-formamide at -5 - 0℃; for 0.916667h;
Stage #2: 2-chloro-N-(4-nitro-phenyl)-acetamide In N,N-dimethyl-formamide at -5 - 30℃;
74%

3159-07-7Relevant articles and documents

The behaviour of some thioxanthene and thianthrene derivatives with hydrazoic acid

Palazzo,Giannola,Caronna

, p. 839 - 841 (1974)

-

Diversity in Heterocycle Synthesis Using α-Iminocarboxylic Acids: Decarboxylation Dichotomy

Laha, Joydev K.,Hunjan, Mandeep Kaur

, p. 2315 - 2323 (2022/02/07)

Despite the structural similarity with imines, α-iminocarboxylic acids have seldom been used in heterocycles synthesis. The reactions of ortho-substituted anilines and arylglyoxylic acids in DMSO at 40 °C gave various benzo-fused five- to six-membered N-heterocycles in good to excellent yields. The reaction proceeds via intramolecular Michael addition of α-iminocarboxylic acids, generated in situ, with an ortho-substituted nucleophile, yielding an isolable unprecedented tetrahedral carboxylic acids, which upon decarboxylation without any aid of additional reagents forms the N-heterocycles. DMSO is crucial in this reaction, perhaps because of improved solubility and the ease of decarboxylation of these tetrahedral carboxylic acids. However, a copper-catalyzed reaction of ortho-substituted anilines and 2-bromoarylglyoxylic acids gave a dibenzo-fused seven-membered N-heterocycle under a basic reaction condition. Unlike intramolecular cyclization with α-iminocarboxylic acids in the first case, α-iminocarboxylic acid undergoes a competitive decarboxylation under the copper-catalyzed conditions, which upon subsequent heteroarylation form the heterocycles. Taken together, the study described herein represents two different modes of decarboxylation observed with α-iminocarboxylic acids, leading to the synthesis of divergent heterocycles and pharmaceuticals, which remained unexplored previously.

Reductive Condensation of a Nitro Group with Carboxylic Acids Promoted by Phosphorus(III) Compounds: A Short Route to 5 H -Dibenzo[ b, e ][1,4]diazepin-11(10 H)-ones

Tryniszewski, Micha?,Bujok, Robert,Gańczarczyk, Roman,Wróbel, Zbigniew

, p. 3086 - 3094 (2020/08/10)

Tributyl- or triphenylphosphine promotes a one-pot, three-step method for the synthesis of differently substituted dibenzodiazepinones from N -aryl-2-nitroanilines. Pyridine analogues and the corresponding thiazepinones can also be formed using this method. The process involves deoxygenation of the nitro group, then formation of an iminophosphorane intermediate and its intramolecular condensation with a carboxyl group placed in the N -aryl group. The role of the carboxyl group in the formation of the iminophosphorane and the mode of cyclization are discussed.

COtab: Expedient and Safe Setup for Pd-Catalyzed Carbonylation Chemistry

Collin, Hugo P.,Reis, Wallace J.,Nielsen, Dennis U.,Lindhardt, Anders T.,Valle, Marcelo S.,Freitas, Rossimiriam P.,Skrydstrup, Troels

supporting information, p. 5775 - 5778 (2019/08/26)

Bench-stable tablets (COtabs) have been developed for the rapid and safe production of carbon monoxide. The tablets can be made in less than 5 min without the use of a glovebox and only require a stock solution of an amine base to liberate a specific quantity of CO in a two-chamber system. The COtabs were tested in five different carbonylation reactions and provided similar yields compared to literature procedures. Finally, a gram-scale reaction was conducted, as well as 13C-isotope labeling of the anticancer drug, olaparib.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3159-07-7